All News about Takeda Pharmaceutical Ltd ADR
Preview: Takeda Pharmaceutical's Earnings
October 30, 2024
Via Benzinga
HUTCHMED Announces Japan Approval for FRUZAQLA® (fruquintinib) Received by Takeda
September 24, 2024
Via GlobeNewswire
Via PressReach
Exposures
Product Safety
Via Benzinga
Takeda Announces New Assignments of Directors
June 26, 2024
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|